Copyright Reports & Markets. All rights reserved.

Global Biological Sample Storage Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Biological Sample Storage Services by Type
    • 1.3.1 Overview: Global Biological Sample Storage Services Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Biological Sample Storage Services Consumption Value Market Share by Type in 2025
    • 1.3.3 Human Clinical Use
    • 1.3.4 Non-Human Use
  • 1.4 Classification of Biological Sample Storage Services by Storage Temperature Range
    • 1.4.1 Overview: Global Biological Sample Storage Services Market Size by Storage Temperature Range: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global Biological Sample Storage Services Consumption Value Market Share by Storage Temperature Range in 2025
    • 1.4.3 -20℃~-80℃
    • 1.4.4 ≤-150℃
  • 1.5 Classification of Biological Sample Storage Services by Full-Process Coverage
    • 1.5.1 Overview: Global Biological Sample Storage Services Market Size by Full-Process Coverage: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global Biological Sample Storage Services Consumption Value Market Share by Full-Process Coverage in 2025
    • 1.5.3 Managed Storage Only
    • 1.5.4 Full-Chain Value-Added Use
  • 1.6 Global Biological Sample Storage Services Market by Application
    • 1.6.1 Overview: Global Biological Sample Storage Services Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Biomedical R&D
    • 1.6.3 Medical Institutions
    • 1.6.4 Other
  • 1.7 Global Biological Sample Storage Services Market Size & Forecast
  • 1.8 Global Biological Sample Storage Services Market Size and Forecast by Region
    • 1.8.1 Global Biological Sample Storage Services Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global Biological Sample Storage Services Market Size by Region, (2021-2032)
    • 1.8.3 North America Biological Sample Storage Services Market Size and Prospect (2021-2032)
    • 1.8.4 Europe Biological Sample Storage Services Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific Biological Sample Storage Services Market Size and Prospect (2021-2032)
    • 1.8.6 South America Biological Sample Storage Services Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa Biological Sample Storage Services Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Thermo Fisher Scientific Inc.
    • 2.1.1 Thermo Fisher Scientific Inc. Details
    • 2.1.2 Thermo Fisher Scientific Inc. Major Business
    • 2.1.3 Thermo Fisher Scientific Inc. Biological Sample Storage Services Product and Solutions
    • 2.1.4 Thermo Fisher Scientific Inc. Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
  • 2.2 Labcorp Holdings Inc.
    • 2.2.1 Labcorp Holdings Inc. Details
    • 2.2.2 Labcorp Holdings Inc. Major Business
    • 2.2.3 Labcorp Holdings Inc. Biological Sample Storage Services Product and Solutions
    • 2.2.4 Labcorp Holdings Inc. Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Labcorp Holdings Inc. Recent Developments and Future Plans
  • 2.3 IQVIA Holdings Inc.
    • 2.3.1 IQVIA Holdings Inc. Details
    • 2.3.2 IQVIA Holdings Inc. Major Business
    • 2.3.3 IQVIA Holdings Inc. Biological Sample Storage Services Product and Solutions
    • 2.3.4 IQVIA Holdings Inc. Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 IQVIA Holdings Inc. Recent Developments and Future Plans
  • 2.4 SciSafe
    • 2.4.1 SciSafe Details
    • 2.4.2 SciSafe Major Business
    • 2.4.3 SciSafe Biological Sample Storage Services Product and Solutions
    • 2.4.4 SciSafe Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 SciSafe Recent Developments and Future Plans
  • 2.5 Clinigen
    • 2.5.1 Clinigen Details
    • 2.5.2 Clinigen Major Business
    • 2.5.3 Clinigen Biological Sample Storage Services Product and Solutions
    • 2.5.4 Clinigen Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Clinigen Recent Developments and Future Plans
  • 2.6 Sampled
    • 2.6.1 Sampled Details
    • 2.6.2 Sampled Major Business
    • 2.6.3 Sampled Biological Sample Storage Services Product and Solutions
    • 2.6.4 Sampled Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Sampled Recent Developments and Future Plans
  • 2.7 Medpace Holdings, Inc.
    • 2.7.1 Medpace Holdings, Inc. Details
    • 2.7.2 Medpace Holdings, Inc. Major Business
    • 2.7.3 Medpace Holdings, Inc. Biological Sample Storage Services Product and Solutions
    • 2.7.4 Medpace Holdings, Inc. Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Medpace Holdings, Inc. Recent Developments and Future Plans
  • 2.8 Resonant Clinical Solutions
    • 2.8.1 Resonant Clinical Solutions Details
    • 2.8.2 Resonant Clinical Solutions Major Business
    • 2.8.3 Resonant Clinical Solutions Biological Sample Storage Services Product and Solutions
    • 2.8.4 Resonant Clinical Solutions Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Resonant Clinical Solutions Recent Developments and Future Plans
  • 2.9 CellCarta
    • 2.9.1 CellCarta Details
    • 2.9.2 CellCarta Major Business
    • 2.9.3 CellCarta Biological Sample Storage Services Product and Solutions
    • 2.9.4 CellCarta Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 CellCarta Recent Developments and Future Plans
  • 2.10 Astoriom
    • 2.10.1 Astoriom Details
    • 2.10.2 Astoriom Major Business
    • 2.10.3 Astoriom Biological Sample Storage Services Product and Solutions
    • 2.10.4 Astoriom Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Astoriom Recent Developments and Future Plans
  • 2.11 Cryoport, Inc.
    • 2.11.1 Cryoport, Inc. Details
    • 2.11.2 Cryoport, Inc. Major Business
    • 2.11.3 Cryoport, Inc. Biological Sample Storage Services Product and Solutions
    • 2.11.4 Cryoport, Inc. Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Cryoport, Inc. Recent Developments and Future Plans
  • 2.12 Precision Medicine Group, LLC
    • 2.12.1 Precision Medicine Group, LLC Details
    • 2.12.2 Precision Medicine Group, LLC Major Business
    • 2.12.3 Precision Medicine Group, LLC Biological Sample Storage Services Product and Solutions
    • 2.12.4 Precision Medicine Group, LLC Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Precision Medicine Group, LLC Recent Developments and Future Plans
  • 2.13 LabConnect
    • 2.13.1 LabConnect Details
    • 2.13.2 LabConnect Major Business
    • 2.13.3 LabConnect Biological Sample Storage Services Product and Solutions
    • 2.13.4 LabConnect Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 LabConnect Recent Developments and Future Plans
  • 2.14 MLM Medical Labs
    • 2.14.1 MLM Medical Labs Details
    • 2.14.2 MLM Medical Labs Major Business
    • 2.14.3 MLM Medical Labs Biological Sample Storage Services Product and Solutions
    • 2.14.4 MLM Medical Labs Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 MLM Medical Labs Recent Developments and Future Plans
  • 2.15 Cerba HealthCare
    • 2.15.1 Cerba HealthCare Details
    • 2.15.2 Cerba HealthCare Major Business
    • 2.15.3 Cerba HealthCare Biological Sample Storage Services Product and Solutions
    • 2.15.4 Cerba HealthCare Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Cerba HealthCare Recent Developments and Future Plans
  • 2.16 Charles River Laboratories
    • 2.16.1 Charles River Laboratories Details
    • 2.16.2 Charles River Laboratories Major Business
    • 2.16.3 Charles River Laboratories Biological Sample Storage Services Product and Solutions
    • 2.16.4 Charles River Laboratories Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Charles River Laboratories Recent Developments and Future Plans
  • 2.17 GenVault
    • 2.17.1 GenVault Details
    • 2.17.2 GenVault Major Business
    • 2.17.3 GenVault Biological Sample Storage Services Product and Solutions
    • 2.17.4 GenVault Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 GenVault Recent Developments and Future Plans
  • 2.18 Evotec SE
    • 2.18.1 Evotec SE Details
    • 2.18.2 Evotec SE Major Business
    • 2.18.3 Evotec SE Biological Sample Storage Services Product and Solutions
    • 2.18.4 Evotec SE Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Evotec SE Recent Developments and Future Plans
  • 2.19 Novotech
    • 2.19.1 Novotech Details
    • 2.19.2 Novotech Major Business
    • 2.19.3 Novotech Biological Sample Storage Services Product and Solutions
    • 2.19.4 Novotech Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Novotech Recent Developments and Future Plans
  • 2.20 ACM Global Laboratories
    • 2.20.1 ACM Global Laboratories Details
    • 2.20.2 ACM Global Laboratories Major Business
    • 2.20.3 ACM Global Laboratories Biological Sample Storage Services Product and Solutions
    • 2.20.4 ACM Global Laboratories Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 ACM Global Laboratories Recent Developments and Future Plans
  • 2.21 Cliantha Research Limited
    • 2.21.1 Cliantha Research Limited Details
    • 2.21.2 Cliantha Research Limited Major Business
    • 2.21.3 Cliantha Research Limited Biological Sample Storage Services Product and Solutions
    • 2.21.4 Cliantha Research Limited Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.21.5 Cliantha Research Limited Recent Developments and Future Plans
  • 2.22 VIMTA Labs Limited
    • 2.22.1 VIMTA Labs Limited Details
    • 2.22.2 VIMTA Labs Limited Major Business
    • 2.22.3 VIMTA Labs Limited Biological Sample Storage Services Product and Solutions
    • 2.22.4 VIMTA Labs Limited Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.22.5 VIMTA Labs Limited Recent Developments and Future Plans
  • 2.23 Mediford Corporation
    • 2.23.1 Mediford Corporation Details
    • 2.23.2 Mediford Corporation Major Business
    • 2.23.3 Mediford Corporation Biological Sample Storage Services Product and Solutions
    • 2.23.4 Mediford Corporation Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.23.5 Mediford Corporation Recent Developments and Future Plans
  • 2.24 Pacific Science, LLC
    • 2.24.1 Pacific Science, LLC Details
    • 2.24.2 Pacific Science, LLC Major Business
    • 2.24.3 Pacific Science, LLC Biological Sample Storage Services Product and Solutions
    • 2.24.4 Pacific Science, LLC Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.24.5 Pacific Science, LLC Recent Developments and Future Plans
  • 2.25 Tobin Scientific
    • 2.25.1 Tobin Scientific Details
    • 2.25.2 Tobin Scientific Major Business
    • 2.25.3 Tobin Scientific Biological Sample Storage Services Product and Solutions
    • 2.25.4 Tobin Scientific Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.25.5 Tobin Scientific Recent Developments and Future Plans
  • 2.26 Wuhan Shengwu Yangbenku Youxian Gongsi
    • 2.26.1 Wuhan Shengwu Yangbenku Youxian Gongsi Details
    • 2.26.2 Wuhan Shengwu Yangbenku Youxian Gongsi Major Business
    • 2.26.3 Wuhan Shengwu Yangbenku Youxian Gongsi Biological Sample Storage Services Product and Solutions
    • 2.26.4 Wuhan Shengwu Yangbenku Youxian Gongsi Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.26.5 Wuhan Shengwu Yangbenku Youxian Gongsi Recent Developments and Future Plans
  • 2.27 Core Cryolab Inc.
    • 2.27.1 Core Cryolab Inc. Details
    • 2.27.2 Core Cryolab Inc. Major Business
    • 2.27.3 Core Cryolab Inc. Biological Sample Storage Services Product and Solutions
    • 2.27.4 Core Cryolab Inc. Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.27.5 Core Cryolab Inc. Recent Developments and Future Plans
  • 2.28 Cryopoint LLC
    • 2.28.1 Cryopoint LLC Details
    • 2.28.2 Cryopoint LLC Major Business
    • 2.28.3 Cryopoint LLC Biological Sample Storage Services Product and Solutions
    • 2.28.4 Cryopoint LLC Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.28.5 Cryopoint LLC Recent Developments and Future Plans
  • 2.29 Trepte Biostorage LLC
    • 2.29.1 Trepte Biostorage LLC Details
    • 2.29.2 Trepte Biostorage LLC Major Business
    • 2.29.3 Trepte Biostorage LLC Biological Sample Storage Services Product and Solutions
    • 2.29.4 Trepte Biostorage LLC Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.29.5 Trepte Biostorage LLC Recent Developments and Future Plans
  • 2.30 LabVendor Inc.
    • 2.30.1 LabVendor Inc. Details
    • 2.30.2 LabVendor Inc. Major Business
    • 2.30.3 LabVendor Inc. Biological Sample Storage Services Product and Solutions
    • 2.30.4 LabVendor Inc. Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.30.5 LabVendor Inc. Recent Developments and Future Plans
  • 2.31 NX Wanbishi Archives Co., Ltd.
    • 2.31.1 NX Wanbishi Archives Co., Ltd. Details
    • 2.31.2 NX Wanbishi Archives Co., Ltd. Major Business
    • 2.31.3 NX Wanbishi Archives Co., Ltd. Biological Sample Storage Services Product and Solutions
    • 2.31.4 NX Wanbishi Archives Co., Ltd. Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.31.5 NX Wanbishi Archives Co., Ltd. Recent Developments and Future Plans
  • 2.32 Tomoe Shokai Co., Ltd.
    • 2.32.1 Tomoe Shokai Co., Ltd. Details
    • 2.32.2 Tomoe Shokai Co., Ltd. Major Business
    • 2.32.3 Tomoe Shokai Co., Ltd. Biological Sample Storage Services Product and Solutions
    • 2.32.4 Tomoe Shokai Co., Ltd. Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.32.5 Tomoe Shokai Co., Ltd. Recent Developments and Future Plans
  • 2.33 Fukushima Cell Factory Co., Ltd.
    • 2.33.1 Fukushima Cell Factory Co., Ltd. Details
    • 2.33.2 Fukushima Cell Factory Co., Ltd. Major Business
    • 2.33.3 Fukushima Cell Factory Co., Ltd. Biological Sample Storage Services Product and Solutions
    • 2.33.4 Fukushima Cell Factory Co., Ltd. Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.33.5 Fukushima Cell Factory Co., Ltd. Recent Developments and Future Plans
  • 2.34 Henan Huapu Yiyao Keji Youxian Gongsi
    • 2.34.1 Henan Huapu Yiyao Keji Youxian Gongsi Details
    • 2.34.2 Henan Huapu Yiyao Keji Youxian Gongsi Major Business
    • 2.34.3 Henan Huapu Yiyao Keji Youxian Gongsi Biological Sample Storage Services Product and Solutions
    • 2.34.4 Henan Huapu Yiyao Keji Youxian Gongsi Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.34.5 Henan Huapu Yiyao Keji Youxian Gongsi Recent Developments and Future Plans
  • 2.35 Shanghai Fenglin Clinical Laboratory Co., Ltd.
    • 2.35.1 Shanghai Fenglin Clinical Laboratory Co., Ltd. Details
    • 2.35.2 Shanghai Fenglin Clinical Laboratory Co., Ltd. Major Business
    • 2.35.3 Shanghai Fenglin Clinical Laboratory Co., Ltd. Biological Sample Storage Services Product and Solutions
    • 2.35.4 Shanghai Fenglin Clinical Laboratory Co., Ltd. Biological Sample Storage Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.35.5 Shanghai Fenglin Clinical Laboratory Co., Ltd. Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Biological Sample Storage Services Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Biological Sample Storage Services by Company Revenue
    • 3.2.2 Top 3 Biological Sample Storage Services Players Market Share in 2025
    • 3.2.3 Top 6 Biological Sample Storage Services Players Market Share in 2025
  • 3.3 Biological Sample Storage Services Market: Overall Company Footprint Analysis
    • 3.3.1 Biological Sample Storage Services Market: Region Footprint
    • 3.3.2 Biological Sample Storage Services Market: Company Product Type Footprint
    • 3.3.3 Biological Sample Storage Services Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Biological Sample Storage Services Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Biological Sample Storage Services Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Biological Sample Storage Services Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Biological Sample Storage Services Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Biological Sample Storage Services Consumption Value by Type (2021-2032)
  • 6.2 North America Biological Sample Storage Services Market Size by Application (2021-2032)
  • 6.3 North America Biological Sample Storage Services Market Size by Country
    • 6.3.1 North America Biological Sample Storage Services Consumption Value by Country (2021-2032)
    • 6.3.2 United States Biological Sample Storage Services Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Biological Sample Storage Services Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Biological Sample Storage Services Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Biological Sample Storage Services Consumption Value by Type (2021-2032)
  • 7.2 Europe Biological Sample Storage Services Consumption Value by Application (2021-2032)
  • 7.3 Europe Biological Sample Storage Services Market Size by Country
    • 7.3.1 Europe Biological Sample Storage Services Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Biological Sample Storage Services Market Size and Forecast (2021-2032)
    • 7.3.3 France Biological Sample Storage Services Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Biological Sample Storage Services Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Biological Sample Storage Services Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Biological Sample Storage Services Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Biological Sample Storage Services Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Biological Sample Storage Services Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Biological Sample Storage Services Market Size by Region
    • 8.3.1 Asia-Pacific Biological Sample Storage Services Consumption Value by Region (2021-2032)
    • 8.3.2 China Biological Sample Storage Services Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Biological Sample Storage Services Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Biological Sample Storage Services Market Size and Forecast (2021-2032)
    • 8.3.5 India Biological Sample Storage Services Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Biological Sample Storage Services Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Biological Sample Storage Services Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Biological Sample Storage Services Consumption Value by Type (2021-2032)
  • 9.2 South America Biological Sample Storage Services Consumption Value by Application (2021-2032)
  • 9.3 South America Biological Sample Storage Services Market Size by Country
    • 9.3.1 South America Biological Sample Storage Services Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Biological Sample Storage Services Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Biological Sample Storage Services Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Biological Sample Storage Services Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Biological Sample Storage Services Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Biological Sample Storage Services Market Size by Country
    • 10.3.1 Middle East & Africa Biological Sample Storage Services Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Biological Sample Storage Services Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Biological Sample Storage Services Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Biological Sample Storage Services Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Biological Sample Storage Services Market Drivers
  • 11.2 Biological Sample Storage Services Market Restraints
  • 11.3 Biological Sample Storage Services Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Biological Sample Storage Services Industry Chain
  • 12.2 Biological Sample Storage Services Upstream Analysis
  • 12.3 Biological Sample Storage Services Midstream Analysis
  • 12.4 Biological Sample Storage Services Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Biological Sample Storage Services market size was valued at US$ 959 million in 2025 and is forecast to a readjusted size of US$ 1418 million by 2032 with a CAGR of 5.7% during review period.
    Biological sample storage services refer to long-term or periodic custody and inventory management services for biological samples provided by professional life science service organizations, biobank operators, central laboratories, CROs, and other third-party organizations with controlled storage infrastructure and sample management capabilities to clients in the pharmaceutical, biotechnology, clinical research, medical, and scientific research fields. Biological sample storage services focus on blood, serum, plasma, PBMCs, tissues, pathological sections, FFPE, cells, cell banks, DNA, RNA, microorganisms, and other research and clinical samples legally owned or managed by clients. Sample integrity is maintained through controlled room temperature, refrigeration at 2–8°C, conventional freezing at -20°C to -40°C, ultra-low temperatures of approximately -70°C to -90°C, and liquid nitrogen gas or liquid phase cryogenic environments below approximately -135°C.
    Key Findings
    Human Clinical Type and Non-human Type define the two storage-object categories covered by Biological Sample Storage Services
    The study separates -20°C to -80°C storage from ≤-150°C deep-cryogenic storage for different specimen preservation requirements
    Managed Storage Only and Full-chain Value-added Services represent distinct service depths from custody to processing logistics and data management
    Biopharmaceutical R&D and medical institutions form the principal application base for long-term controlled biological sample preservation
    The competitive scope covers 35 studied providers spanning laboratories specialist biorepositories cold-chain platforms and regional service operators
    Market Trends
    Biological Sample Storage Services is evolving from freezer-space outsourcing toward integrated sample-lifecycle management in which physical storage, chain of custody, digital inventory, quality systems, logistics and downstream analytical readiness are increasingly connected. The 2026 fourth edition of the U.S. National Cancer Institute Best Practices for Biospecimen Resources places renewed emphasis on standardized collection, processing, storage, retrieval, distribution, quality management and informatics because pre-analytical variation can directly affect the reproducibility of research results. Commercial service models are moving in the same direction. Sampled integrates shipping, storage, sample management, bioanalytics and reporting, while Cryoport combines biostorage with sample management, packaging, labeling and logistics for biologics and advanced therapies. At the infrastructure level, continuous temperature monitoring, redundant power and storage capacity, digital traceability and disaster-recovery planning are becoming standard differentiators. The long-term direction is therefore toward higher automation, better real-time sample visibility, stronger business-continuity systems and service platforms capable of maintaining specimen integrity from receipt through final retrieval or downstream use.
    Market Dynamics
    Drivers
    Demand for Biological Sample Storage Services is supported by growth in clinical trials, translational research, biomarker programs, precision medicine, cell and gene therapy development and longitudinal research, all of which generate valuable specimens that may need to be preserved for years. The NCI emphasizes that the reliability of molecular data derived from human biospecimens depends on the quality and consistency of specimens and associated clinical data, increasing the importance of controlled collection, processing and storage. Outsourcing also enables pharmaceutical companies, CROs, hospitals and research institutes to avoid building dedicated freezer or cryogenic infrastructure while gaining validated monitoring, backup systems and specialist operating procedures. Labcorp provides global biorepository capability for clinical trial specimens, while Thermo Fisher's biobanking workflow links collection, preparation, storage, inventory management and transportation. As sample volumes and study complexity increase, centralized storage can also improve standardization across multi-site research programs.
    Restraints
    The market is constrained by high requirements for infrastructure reliability, regulatory compliance, sample-specific SOPs and long-term operating continuity. Ultra-low-temperature freezers and cryogenic systems require continuous power, alarm monitoring, preventive maintenance, backup capacity and emergency response, while specimen relocation during an equipment failure can itself create quality risk. Sample type also determines appropriate processing, containers, storage temperature and acceptable freeze-thaw exposure, limiting standardization across projects. NCI best practices stress that biospecimen handling factors can affect downstream molecular measurements and therefore require documented quality and operational controls. For human clinical specimens, providers must additionally manage consent-related restrictions, privacy, confidentiality, authorized access and permitted future use of associated data. The NCI's 2026 governance framework highlights these responsibilities as part of responsible biospecimen custodianship. These requirements raise fixed costs and favor providers with mature quality systems and validated infrastructure.
    Opportunities
    Full-chain Value-added Services represent the principal service-expansion opportunity because customers increasingly require more than frozen-space capacity. Services can extend to accessioning, barcode registration, aliquoting, sample processing, kit preparation, clinical logistics, retrieval, distribution, data management and downstream analytical workflows. Sampled operates an integrated analytical biorepository with LIMS-based chain-of-custody management, while Cryoport combines biostorage with kit production, packaging, labeling, clinical sample management and supply-chain services. Deep-cryogenic ≤-150°C storage creates another specialized opportunity around viable cells, cell therapies and other temperature-sensitive biological materials. Astoriom provides storage extending to -196°C and integrates inventory monitoring, transport and disaster-protection services, illustrating the increasing value of combined storage and risk-management capability. Digitalization provides additional upside through client portals, automated location tracking, electronic audit trails and real-time inventory visibility, helping biopharma sponsors manage samples distributed across laboratories and geographies.
    Challenges
    The core challenge is preserving both biological quality and information integrity over potentially very long storage periods. Temperature excursions, repeated freeze-thaw cycles, incorrect sample identification, container failure, liquid-nitrogen interruptions or incomplete metadata can reduce or eliminate the scientific value of irreplaceable specimens. The NCI's 2026 best practices therefore address collection, processing, storage, retrieval, distribution, QA/QC and inventory control as interconnected activities. Business-continuity planning is equally critical because a single freezer or facility event can affect large specimen collections; commercial biorepositories increasingly use redundant freezers, backup generators, independent environmental monitoring and contingency capacity. SciSafe highlights uninterrupted-energy procedures and round-the-clock monitoring, while CellCarta maintains backup generators and redundant freezer capacity for clinical-study samples. Providers must also maintain technology compatibility and data accessibility over long projects, creating continuing investment requirements in LIMS, cybersecurity, validated monitoring systems and equipment renewal.
    Value Chain Analysis
    The upstream value chain of Biological Sample Storage Services consists of storage infrastructure, consumables, information systems and specialist scientific inputs. Core physical resources include -20°C and ultra-low-temperature freezers, cryogenic tanks and liquid-nitrogen infrastructure, temperature probes, environmental monitoring systems, backup power, alarms, racking, cryovials, barcoded tubes, boxes and transport containers. Supporting digital infrastructure includes LIMS, barcode and RFID identification, client portals, audit trails, access control and chain-of-custody systems. Sample-specific inputs such as collection kits, stabilizers, cryoprotectants and validated processing protocols determine whether material enters storage in a condition suitable for future research. Thermo Fisher's biobanking workflow links preparation, storage, monitoring, LIMS tracking and controlled transportation, demonstrating the interdependence of these upstream elements.
    Midstream service providers undertake sample receipt, inspection, accessioning, registration, temperature-controlled storage, inventory management, retrieval and distribution. Full-chain Value-added Services extend further into aliquoting, processing, kit logistics, data management, analytical routing, relocation, destruction and disaster recovery. Sampled describes biobanking as the management of receiving, accessioning, cataloging, handling, storage and retrieval, with chain of custody and associated data maintained throughout the sample lifecycle. Downstream users are primarily biopharmaceutical R&D organizations, medical institutions and other research bodies. Value is concentrated in reliable custody, documented quality, traceability, rapid retrieval, compliance and the ability to protect irreplaceable samples over long periods, rather than storage volume alone.
    Segment Insights
    By storage object, Human Clinical Type has more complex governance and documentation requirements because samples are frequently linked to participant information, informed consent, clinical protocols and defined future-use permissions. Human blood, serum, plasma, tissue, PBMCs and other clinical specimens may also support biomarker discovery, clinical trials and longitudinal research, making chain-of-custody and associated-data integrity particularly important. NCI defines a biospecimen resource as encompassing human specimens, associated data, the physical storage structure and related processes and policies, reflecting the integrated nature of this segment. Non-human Type covers animal, microbial and other research specimens and generally has a different governance profile, while still requiring sample-specific preservation conditions and traceability.
    By temperature range, -20°C to -80°C supports a broad spectrum of frozen biological samples and is widely compatible with mechanical freezer infrastructure, while ≤-150°C is oriented toward deep-cryogenic preservation where maintenance of viable cells or highly temperature-sensitive material requires substantially lower temperatures. Commercial biorepositories demonstrate this separation in practice: Astoriom offers ultra-low storage at -20°C to -80°C and cryogenic storage at -150°C to -196°C, while SciSafe provides cryogenic storage between -196°C and -150°C alongside ultra-cold services. The higher-value opportunity increasingly comes from matching the appropriate temperature environment with processing, monitoring, data and logistics services.
    Downstream Market Opportunities
    Biopharmaceutical R&D is a major opportunity area because drug discovery, biomarker programs, clinical trials, precision medicine and advanced therapies generate growing quantities of specimens that may need to remain accessible throughout development and regulatory timelines. Cryoport positions biostorage within an integrated platform supporting biologics, cell therapy and gene therapy from development toward commercialization, while Sampled combines sample storage with multiomics, cellular services and logistics. Medical institutions represent another important customer group, particularly where hospitals and clinical laboratories need secure long-term custody without committing to additional freezer rooms, cryogenic infrastructure and 24-hour monitoring resources. Other opportunities include government research repositories, universities, population studies and specialist research organizations. Demand in these settings increasingly favors providers that can offer standardized sample intake, rapid retrieval, secure data access and auditable transfer between storage facilities, analytical laboratories and research teams.
    Regional Insights
    North America and Europe are mature service clusters for Biological Sample Storage Services, supported by dense biopharmaceutical, CRO, central-laboratory and academic research infrastructure together with established biobanking quality frameworks. The research scope includes global and regional providers such as Thermo Fisher Scientific Inc., Labcorp Holdings Inc., IQVIA Holdings Inc., SciSafe, Sampled, CellCarta, Astoriom, Cryoport, Inc., Precision Medicine Group, LLC and LabConnect. Labcorp operates multiple global biorepository locations, SciSafe maintains facilities in the United States and Europe, Astoriom operates biorepositories in the United States, United Kingdom and Ireland, and CellCarta reports sample-storage facilities in the United States, Belgium and China. This cross-border footprint reflects demand for geographically distributed storage close to clinical and analytical operations.
    Asia-Pacific is increasingly important as biopharmaceutical R&D, clinical development and hospital research infrastructure expand and as customers seek local custody of specimens to reduce cross-border logistics complexity. The research scope includes providers in China and Japan alongside global companies with Asian operations, including Wuhan Biobank Co., Ltd., Henan Huapu Pharmaceutical Technology Co., Ltd., Shanghai Fenglin Pharmaceutical Medical Laboratory Co., Ltd., NX Wanbishi Archives Co., Ltd., Tomoe Shokai Co., Ltd. and Fukushima Cell Factory Co., Ltd. CellCarta's biorepository footprint in China illustrates the internationalization of sample-management capacity in the region. Regional competitive opportunities depend on local clinical-research activity, regulatory requirements for human specimens and data, access to validated cryogenic infrastructure and the ability to connect domestic storage with international study networks.
    Competitive Landscape Analysis
    The Biological Sample Storage Services market combines diversified life-science service groups, central laboratories, specialist biorepositories, clinical-sample logistics platforms and regional storage providers. Thermo Fisher Scientific Inc. has broad biobanking capabilities spanning collection, preparation, cold storage, LIMS-based tracking and transport, while Labcorp integrates specimen management and long-term biorepository services into its central-laboratory infrastructure. Specialist providers compete through deeper storage focus and operational resilience: SciSafe covers ultra-cold and cryogenic biostorage with validated monitoring and regulatory-oriented operations; Astoriom spans temperature conditions down to -196°C and combines biorepository storage with inventory intelligence, transport and disaster protection; Sampled links high-capacity biobanking with sample management, multiomics and data systems; Cryoport integrates biostorage into a wider advanced-therapy logistics and BioServices platform. CellCarta, Precision Medicine Group, LabConnect, MLM Medical Labs, Cerba HealthCare, Charles River Laboratories, Evotec SE, Novotech and other confirmed providers further connect storage with clinical research, laboratory or development workflows, while specialist regional operators broaden geographic coverage. Competitive differentiation is increasingly determined by validated temperature range, infrastructure redundancy, sample and data traceability, global logistics, regulatory quality systems, retrieval responsiveness and the ability to provide Full-chain Value-added Services around the stored specimen.
    Report Scope
    This report is a detailed and comprehensive analysis for global Biological Sample Storage Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Biological Sample Storage Services market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Biological Sample Storage Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Biological Sample Storage Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Biological Sample Storage Services market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Biological Sample Storage Services
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Biological Sample Storage Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Labcorp Holdings Inc., IQVIA Holdings Inc., SciSafe, Clinigen, Sampled, Medpace Holdings, Inc., Resonant Clinical Solutions, CellCarta, Astoriom, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Biological Sample Storage Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    Market segment by Type
    Human Clinical Use
    Non-Human Use
    Market segment by Storage Temperature Range
    -20℃~-80℃
    ≤-150℃
    Market segment by Full-Process Coverage
    Managed Storage Only
    Full-Chain Value-Added Use
    Market segment by Application
    Biomedical R&D
    Medical Institutions
    Other
    Market segment by players, this report covers
    Thermo Fisher Scientific Inc.
    Labcorp Holdings Inc.
    IQVIA Holdings Inc.
    SciSafe
    Clinigen
    Sampled
    Medpace Holdings, Inc.
    Resonant Clinical Solutions
    CellCarta
    Astoriom
    Cryoport, Inc.
    Precision Medicine Group, LLC
    LabConnect
    MLM Medical Labs
    Cerba HealthCare
    Charles River Laboratories
    GenVault
    Evotec SE
    Novotech
    ACM Global Laboratories
    Cliantha Research Limited
    VIMTA Labs Limited
    Mediford Corporation
    Pacific Science, LLC
    Tobin Scientific
    Wuhan Shengwu Yangbenku Youxian Gongsi
    Core Cryolab Inc.
    Cryopoint LLC
    Trepte Biostorage LLC
    LabVendor Inc.
    NX Wanbishi Archives Co., Ltd.
    Tomoe Shokai Co., Ltd.
    Fukushima Cell Factory Co., Ltd.
    Henan Huapu Yiyao Keji Youxian Gongsi
    Shanghai Fenglin Clinical Laboratory Co., Ltd.
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    Chapter Outline
    Chapter 1, to describe Biological Sample Storage Services product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Biological Sample Storage Services, with revenue, gross margin, and global market share of Biological Sample Storage Services from 2021 to 2026.
    Chapter 3, the Biological Sample Storage Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Biological Sample Storage Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Biological Sample Storage Services.
    Chapter 13, to describe Biological Sample Storage Services research findings and conclusion.

    Buy now